Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/11/2025

Ureaplasma Screening Recommendations

Introduction to Ureaplasma

  • The Infectious Diseases Society of America recommends against routine testing for Ureaplasma urealyticum in asymptomatic individuals due to the high prevalence of colonization in asymptomatic, sexually active people 1
  • Current guidelines do not recommend routine testing for Ureaplasma urealyticum in asymptomatic individuals, as stated by the Infectious Diseases Society of America 1

Antimicrobial Stewardship

  • Treating asymptomatic bacteriuria (including Ureaplasma) is generally not recommended due to concerns about antibiotic resistance, as suggested by The Journal of Urology and Clinical Infectious Diseases 2, 3
  • Unnecessary antibiotic use contributes to the pressing concerns of antibiotic resistance and contradicts principles of antibiotic stewardship, according to The Journal of Urology 2

Specific Clinical Contexts

  • The Centers for Disease Control and Prevention recommends targeting Chlamydia trachomatis as the primary cause of Non-gonococcal Urethritis (NGU), while Ureaplasma urealyticum is implicated in 20-40% of NGU cases, as stated in MMWR Recommendations and Reports 4, 5
  • In asymptomatic individuals with neurogenic lower urinary tract dysfunction, guidelines explicitly recommend against surveillance/screening urine testing, including cultures that might detect Ureaplasma, as recommended by The Journal of Urology 2